Phase 2 Intermediate Risk Acute Myeloid Leukemia Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML

Acute Myeloid LeukemiaIntermediate Risk Acute Myeloid LeukemiaFLT3 Internal Tandem Duplication Positive+1 more

First Affiliated Hospital of Zhejiang University25 enrolled1 locationNCT07259707

Recruiting

Phase 2

Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients

High-Risk Acute Myeloid LeukemiaIntermediate Risk Acute Myeloid Leukemia

The First Affiliated Hospital of Soochow University60 enrolled1 locationNCT06394011